Loading...
Variability in market uptake of psychotropic medications in Europe reflects cultural diversity.
Hoebert, J M Mantel-Teeuwisse, A K Leufkens, H G M van Dijk, L
Hoebert, J M
Mantel-Teeuwisse, A K
Leufkens, H G M
van Dijk, L
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2017-11-06
Year of publication
Files
Loading...
s12913-017-2649-6.pdf
Adobe PDF, 599.94 KB
Research Projects
Organizational Units
Journal Issue
Title
Variability in market uptake of psychotropic medications in Europe reflects cultural diversity.
Translated Title
Published in
BMC Health Serv Res 2017; 17(1):702
Abstract
In the last 20-30 years, many international studies have found substantial differences in the use of (older) psychotropic medication between European countries. The majority mentioned an important role for attitudes and beliefs towards psychotropic medication. So far, no studies have looked into the effects of cultural diversity on the use of new medications entering the market. As national cultures relate deeply to held values regarding, for example, what is seen as effective versus ineffective or safe versus dangerous, (cultural) diversity in decision making around the role of new medications in clinical practice may already be expected from the first day after market authorization.